المؤلفون: Acher, Francine, Cabayé, Alexandre, Eshak, Floriane, Goupil-Lamy, Anne, Pin, Jean-Philippe

المساهمون: UFR Sciences Fondamentales et Biomédicales Sciences - Université Paris Cité, Université Paris Cité (UPCité), Dassault Systèmes, Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), F.A. was supported by the Science Ambassador Program from Dassault Systèmes BIOVIA. A.C. was supported by the Association Nationale de la Recherche et de la Technologie (ANRT) and Dassault Systèmes BIOVIA (CIFRE PhD scholarship no. 2018/0027) and F.E by the AgenceNationale de la Recherche (ANR 2020 NANO4SCHIZO)., ANR-20-CE18-0011,Nano4Schizo,Les nanobodies des récepteurs mGlu comme agents pharmacologiques innovants pour le traitement des symptômes de la schizophrénie(2020)

المصدر: ISSN: 0028-3908.

مصطلحات موضوعية: 3D-structure, Antagonists, Binding site, Orthosteric agonists, Selectivity, Venus flytrap, MESH: Allosteric Regulation, MESH: Binding Sites, MESH: Drug Discovery, MESH: Humans, MESH: Ligands, MESH: Molecular Conformation, MESH: Molecular Targeted Therapy, MESH: Nervous System Diseases, MESH: Receptors, Metabotropic Glutamate, MESH: Synaptic Transmission, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences

Relation: info:eu-repo/semantics/altIdentifier/pmid/34813860; PUBMED: 34813860

الاتاحة: https://hal.science/hal-04712201
https://hal.science/hal-04712201v1/document
https://hal.science/hal-04712201v1/file/S002839082100441X.pdf
https://doi.org/10.1016/j.neuropharm.2021.108886

المؤلفون: Darwiche, Walaa, Gomila, Cathy, Ouled-Haddou, Hakim, Naudot, Marie, Doualle, Cécile, Morel, Pierre, Nguyen-Khac, Florence, Garçon, Loïc, Marolleau, Jean-Pierre, Ghamlouch, Hussein

المساهمون: HEMATIM - Hématopoïèse et immunologie - UR UPJV 4666 (HEMATIM), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Picardie Jules Verne (UPJV), Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), CHU Amiens-Picardie, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Dynamique moléculaire de la transformation hématopoïétique (Dynamo), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay

المصدر: ISSN: 1756-9966 ; Journal of experimental & clinical cancer research ; https://hal.sorbonne-universite.fr/hal-03280761 ; Journal of experimental & clinical cancer research, 2020, 39 (1), pp.228. ⟨10.1186/s13046-020-01738-0⟩.

مصطلحات موضوعية: Ascorbic acid, Chronic lymphocytic leukemia, Cytotoxicity, Drug combination, Vitamin C, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Antioxidants, MESH: Drug Synergism, MESH: Drug Therapy, Combination, MESH: Humans, MESH: Leukemia, Lymphocytic, Chronic, B-Cell, MESH: Molecular Targeted Therapy, MESH: Tumor Cells, Cultured, MESH: Apoptosis, MESH: Ascorbic Acid, MESH: Biomarkers, Tumor, MESH: Case-Control Studies, MESH: Cell Proliferation, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/33115525; hal-03280761; https://hal.sorbonne-universite.fr/hal-03280761; https://hal.sorbonne-universite.fr/hal-03280761/document; https://hal.sorbonne-universite.fr/hal-03280761/file/s13046-020-01738-0.pdf; PUBMED: 33115525; PUBMEDCENTRAL: PMC7594454

الاتاحة: https://hal.sorbonne-universite.fr/hal-03280761
https://hal.sorbonne-universite.fr/hal-03280761/document
https://hal.sorbonne-universite.fr/hal-03280761/file/s13046-020-01738-0.pdf
https://doi.org/10.1186/s13046-020-01738-0

المؤلفون: Gütschow, Michael, Vanden Eynde, Jean Jacques, Jampilek, Josef, Kang, Congbao, Mangoni, Arduino Aleksander, Fossa, Paola, Karaman, Rafik, Trabocchi, Andrea, Scott, Peter, Reynisson, Jóhannes, Rapposelli, Simona, Galdiero, Stefania, Winum, Jean-Yves, Brullo, Chiara, Prokai-Tatrai, Katalin, Sharma, Arun, Schapira, Matthieu, Azuma, Yasu-Taka, Cerchia, Laura, Spetea, Mariana, Torri, Giangiacomo, Collina, Simona, Geronikaki, Athina, García-Sosa, Alfonso, Vasconcelos, M. Helena, de Sousa, Maria Emília, Kosalec, Ivan, Tuccinardi, Tiziano, Duarte, Iola, Salvador, Jorge, Bertinaria, Massimo, Pellecchia, Maurizio, Amato, Jussara, Rastelli, Giulio, Gomes, Paula, Guedes, Rita, Sabatier, Jean-Marc, Estévez-Braun, Ana, Pagano, Bruno, Mangani, Stefano, Ragno, Rino, Kokotos, George, Brindisi, Margherita, González, Florenci, Borges, Fernanda, Miloso, Mariarosaria, Rautio, Jarkko, Muñoz-Torrero, Diego

المساهمون: Universität Bonn = University of Bonn, Université de Mons / University of Mons (UMONS), Comenius University in Bratislava, Flinders University of South Australia, Technische Universität Dresden = Dresden University of Technology (TU Dresden), Université de Genève = University of Geneva (UNIGE), Al-Quds University, Università degli studi della Basilicata = University of Basilicata (UNIBAS), Dipartimento di Chimica 'Ugo Schiff' Sesto Fiorentino (DICUS UniFI), Università degli Studi di Firenze = University of Florence = Université de Florence (UniFI), University of Michigan Ann Arbor, University of Michigan System, Keele University Keele, University of Pisa Italy = Università di Pisa Italia = Université de Pise Italie (UniPi), Second University of Naples-Caserta, University of Naples Federico II = Università degli studi di Napoli Federico II, Institut des Biomolécules Max Mousseron Pôle Chimie Balard (IBMM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Università degli studi di Genova = University of Genoa (UniGe), University of North Texas Health Science Center Fort Worth, Penn State College of Medicine, Pennsylvania Commonwealth System of Higher Education (PCSHE)-Penn State System, University of Toronto, Osaka Prefecture University, Centro di Ateneo di Studi e Attività Spaziali “Giuseppe Colombo” (CISAS), Università degli Studi di Padova = University of Padua (Unipd), Leopold Franzens Universität Innsbruck - University of Innsbruck, Università degli Studi di Pavia Italia = University of Pavia Italy = Université de Pavie Italie (UNIPV), Aristotle University of Thessaloniki, University of Tartu, Universidade do Porto = University of Porto, University of Zagreb, CIDMA - University of Aveiro, Universidade de Coimbra = University of Coimbra Portugal (UC), Università degli studi di Torino = University of Turin (UNITO), University of California Riverside (UC Riverside), University of California (UC), "Federico II" University of Naples Medical School, Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Faculdade de Ciências da Universidade do Porto (FCUP), Universidade de Lisboa = University of Lisbon = Université de Lisbonne (ULISBOA), Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Universidad de La Laguna Tenerife - SP (ULL), Università degli Studi di Siena = University of Siena (UNISI), Università degli Studi di Roma "La Sapienza" = Sapienza University Rome (UNIROMA), National Technical University of Athens Athens (NTUA), Universitat Jaume I = Jaume I University, Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), University of Eastern Finland, Universitat de Barcelona (UB)

المصدر: ISSN: 1420-3049 ; Molecules ; https://amu.hal.science/hal-03170754 ; Molecules, 2020, 25 (13), pp.2968. ⟨10.3390/molecules25132968⟩.

مصطلحات موضوعية: MESH: Animals, MESH: Chemistry, Pharmaceutical, MESH: Drug Discovery, MESH: Humans, MESH: Molecular Targeted Therapy, MESH: Pharmaceutical Preparations, MESH: Structure-Activity Relationship, [SDV]Life Sciences [q-bio], [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Relation: info:eu-repo/semantics/altIdentifier/pmid/32605268; PUBMED: 32605268; PUBMEDCENTRAL: PMC7412072; WOS: 000550306600001

الاتاحة: https://amu.hal.science/hal-03170754
https://amu.hal.science/hal-03170754v1/document
https://amu.hal.science/hal-03170754v1/file/molecules-25-02968.pdf
https://doi.org/10.3390/molecules25132968

المؤلفون: Eslami-S, Zahra, Cortés-Hernández, Luis Enrique, Alix-Panabières, Catherine

المساهمون: Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM)

المصدر: ISSN: 2073-4409 ; Cells ; https://hal.umontpellier.fr/hal-03367929 ; Cells, 2020, 9 (8), pp.1836. ⟨10.3390/cells9081836⟩.

مصطلحات موضوعية: circulating tumor cells, epithelial cancer, epithelial cell adhesion molecule, epithelial-to-mesenchymal transition, epithelial-tomesenchymal transition, MESH: Biomarkers, Tumor, MESH: Epithelial Cell Adhesion Molecule, MESH: Epithelial-Mesenchymal Transition, MESH: Gene Expression Regulation, Neoplastic, MESH: Humans, MESH: Molecular Targeted Therapy, MESH: Neoplasm Metastasis, MESH: Neoplasms, MESH: Neoplastic Cells, Circulating, MESH: Prognosis, [SDV.BC]Life Sciences [q-bio]/Cellular Biology

Relation: info:eu-repo/semantics/altIdentifier/pmid/32764280; hal-03367929; https://hal.umontpellier.fr/hal-03367929; https://hal.umontpellier.fr/hal-03367929/document; https://hal.umontpellier.fr/hal-03367929/file/cells-09-01836.pdf; PUBMED: 32764280; PUBMEDCENTRAL: PMC7464831

الاتاحة: https://hal.umontpellier.fr/hal-03367929
https://hal.umontpellier.fr/hal-03367929/document
https://hal.umontpellier.fr/hal-03367929/file/cells-09-01836.pdf
https://doi.org/10.3390/cells9081836

المؤلفون: Busserolles, Jérôme, Lolignier, Stéphane, Kerckhove, Nicolas, Bertin, Célian, Authier, Nicolas, Eschalier, Alain

المساهمون: Neuro-Dol (Neuro-Dol), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 ), Institut Analgesia, ANR-16-IDEX-0001,CAP 20-25,CAP 20-25(2016)

المصدر: ISSN: 0163-7258.

مصطلحات موضوعية: Analgesia, Innovative targets, Mu opioid receptors (MORs), Opioid abuse and misuse, Opioid adverse side effects, Opioid receptor signaling, MESH: Analgesics, Opioid, MESH: Opioid-Related Disorders, MESH: Ligands, MESH: Molecular Targeted Therapy, MESH: Opioid Epidemic, MESH: Opioid Peptides, MESH: Pain, MESH: Pain Threshold, MESH: Receptors, mu, MESH: Signal Transduction, MESH: Animals, MESH: Central Nervous System, MESH: Drug Discovery, MESH: Humans, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/32165137; hal-03490336; https://hal.science/hal-03490336; https://hal.science/hal-03490336/document; https://hal.science/hal-03490336/file/S0163725820300474.pdf; PII: S0163-7258(20)30047-4; PUBMED: 32165137

الاتاحة: https://hal.science/hal-03490336
https://hal.science/hal-03490336/document
https://hal.science/hal-03490336/file/S0163725820300474.pdf
https://doi.org/10.1016/j.pharmthera.2020.107519

المؤلفون: Peraudeau, E., Cronier, L., Monvoisin, A., Poinot, P., Mergault, C., Guilhot, F., Tranoy-Opalinski, I., Renoux, B., Papot, S., Clarhaut, J.

المساهمون: Signalisation et Transports Ioniques Membranaires (STIM Poitiers ), Université de Poitiers = University of Poitiers (UP)-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Institut de chimie des milieux et matériaux de Poitiers UMR 7285 (IC2MP Poitiers ), Université de Poitiers = University of Poitiers (UP)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie ), INSERM CIC 0802 (INSERM - CHU de Poitiers), Université de Poitiers = University of Poitiers (UP)-Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie )-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: ISSN: 0168-3659.

مصطلحات موضوعية: Folate receptor, Targeted drug delivery, Dexamethasone, Valproic acid, Monomethyl auristatin E, MESH: Animals, MESH: Cell Line, MESH: Mice, Inbred BALB C, MESH: Molecular Targeted Therapy, MESH: Neoplasms, MESH: Oligopeptides, MESH: Up-Regulation, MESH: Valproic Acid, MESH: Dexamethasone, MESH: Female, MESH: Folate Receptor 1, MESH: Humans, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/29129656; PUBMED: 29129656

الاتاحة: https://hal.science/hal-02122599
https://hal.science/hal-02122599v1/document
https://hal.science/hal-02122599v1/file/Peraudeau%20-%20Revision.pdf
https://doi.org/10.1016/j.jconrel.2017.11.011

المؤلفون: Kaley, Thomas, Touat, Mehdi, Subbiah, Vivek, Hollebecque, Antoine, Rodon, Jordi, Lockhart, a Craig, Keedy, Vicki, Bielle, Franck, Hofheinz, Ralf-Dieter, Joly, Florence, Blay, Jean-Yves, Chau, Ian, Puzanov, Igor, Raje, Noopur, S, Wolf, Jurgen, Deangelis, Lisa, M, Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany, Baselga, Jose, Hyman, David, M, Lockhart, A. Craig

المساهمون: Memorial Sloane Kettering Cancer Center New York, Weill Medical College of Cornell University New York, Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Dana-Farber Cancer Institute Boston, Institut Gustave Roussy (IGR), Département de médecine oncologique Gustave Roussy, Département d’Innovation Thérapeutique et essais précoces Gustave Roussy (DITEP), Vall d'Hebron University Hospital Barcelona, University of Miami, MD Anderson Cancer Center Houston, The University of Texas Health Science Center at Houston (UTHealth), Vanderbilt University Medical Center Nashville, Vanderbilt University Nashville, University Hospital Mannheim, Centre Régional de Lutte contre le Cancer François Baclesse Caen (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Léon Bérard Lyon, The Royal Marsden NHS Foundation Trust London, Roswell Park Cancer Institute Buffalo (RPCI), Massachusetts General Hospital Boston, Fraunhofer Institute for Reliability and Microintegration (Fraunhofer IZM), Fraunhofer (Fraunhofer-Gesellschaft), Universitätsklinikum Köln (Uniklinik Köln), F. Hoffmann-La Roche Basel, Genentech, Inc. San Francisco

المصدر: ISSN: 0732-183X.

مصطلحات موضوعية: MESH: Adult, MESH: Brain Neoplasms, MESH: Middle Aged, MESH: Molecular Targeted Therapy, MESH: Multivariate Analysis, MESH: Mutation, MESH: Neoplasm Invasiveness, MESH: Neoplasm Staging, MESH: Prognosis, MESH: Protein Kinase Inhibitors, MESH: Proto-Oncogene Proteins B-raf, MESH: Risk Assessment, MESH: Disease-Free Survival, MESH: Survival Analysis, MESH: Treatment Outcome, MESH: Vemurafenib, MESH: Young Adult, MESH: Female, MESH: Gene Expression Regulation, Neoplastic, MESH: Glioma, MESH: Humans, MESH: Internationality, MESH: Kaplan-Meier Estimate, MESH: Male, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/30351999; PUBMED: 30351999; PUBMEDCENTRAL: PMC6286161

الاتاحة: https://hal.sorbonne-universite.fr/hal-04541090
https://hal.sorbonne-universite.fr/hal-04541090v1/document
https://hal.sorbonne-universite.fr/hal-04541090v1/file/kaley-et-al-2018-braf-inhibition-in-brafv600-mutant-gliomas-results-from-the-ve-basket-study.pdf
https://doi.org/10.1200/JCO.2018.78.9990

المؤلفون: Déprez-Poulain, Rebecca, Hennuyer, Nathalie, Bosc, Damien, Liang, Wenguang, Enée, Emmanuelle, Marechal, Xavier, Charton, Julie, Totobenazara, Jane, Berte, Gonzague, Jahklal, Jouda, Verdelet, Tristan, Dumont, Julie, Dassonneville, Sandrine, Woitrain, Eloise, Gauriot, Marion, Paquet, Charlotte, Duplan, Isabelle, Hermant, Paul, Cantrelle, François- Xavier, Sevin, Emmanuel, Culot, Maxime, Landry, Valérie, Herledan, Adrien, Piveteau, Catherine, Lippens, Guy, Leroux, Florence, Tang, Wei-Jen, van Endert, Peter, Staels, Bart, Déprez, Benoit

المساهمون: Biostructures et Decouverte de Medicament, Institut Pasteur de Lille, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Droit et Santé, Pasteur Network (Réseau International des Instituts Pasteur), Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 (RNMCD), Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), The University of Chicago Medicine Chicago, Institut National de la Santé et de la Recherche Médicale (INSERM), Mécanismes de la Tumorigénèse et Thérapies Ciblées - UMR 8161 (M3T), Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre National de la Recherche Scientifique (CNRS), Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Université d'Artois (UA), Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Médicaments et molécules pour les systèmes vivants - U 1177 (M2SV), Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Unité de Glycobiologie Structurale et Fonctionnelle - UMR 8576 (UGSF), Université de Lille-Centre National de la Recherche Scientifique (CNRS), Ben May Institute Cancer Research, University of Chicago, Université Paris Descartes - Paris 5 (UPD5), The authors acknowledge support from Qing Guo for technical assistance and Hélène Gras-Masse for fruitful discussions. INSERM, University of Lille 2, Institut Pasteur de Lille, Region Nord Pas de Calais, EDFR, Etat (0823007, 0823008, 07-CPER 009-01, 2007-0172-02-CPER/3), Foundation pour la Recherche Médicale (grant DCM20111223046), National Institute of Health (GM81539), and Institute of Translational Medicine (CTSA UL1 TR000430), Agence Nationale de la recherche (grant ANR-11-JS07-015-01) are thanked for funding. M.G. and G.B. are recipients of a fellowship from Ministère de la Recherche et de l′Enseignement Supérieur. Structure results are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357, ANR-11-JS07-0015,CHEM-CRYPTIDASES,Design rationnel et synthèse d'outils pour l'exploration par chemo-biologie des protéases à crypte(2011)

المصدر: ISSN: 2041-1723.

مصطلحات موضوعية: MESH: Animals, MESH: Caco-2 Cells, MESH: Hydroxamic Acids/chemical synthesis, MESH: Hydroxamic Acids/pharmacology, MESH: Insulysin/antagonists & inhibitors, MESH: Hydroxamic Acids/therapeutic use, MESH: Male, MESH: Mice, Inbred C57BL, MESH: Microsomes, Liver, MESH: Molecular Targeted Therapy, MESH: Random Allocation, MESH: Triazoles/chemical synthesis, MESH: Structure-Activity Relationship, MESH: Triazoles/pharmacology, MESH: Catalytic Domain, MESH: Triazoles/therapeutic use, MESH: Diabetes Mellitus/drug therapy, MESH: Drug Evaluation, Preclinical, MESH: Glucose Tolerance Test, MESH: Humans, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/26394692; PUBMED: 26394692; PUBMEDCENTRAL: PMC4580987

الاتاحة: https://univ-artois.hal.science/hal-02511111
https://univ-artois.hal.science/hal-02511111v1/document
https://univ-artois.hal.science/hal-02511111v1/file/catalyting_site_inhibition_of_insulin_degrading.pdf
https://doi.org/10.1038/ncomms9250

المؤلفون: Renaud, Stéphanie, Corcé, Vincent, Cannie, Isabelle, Ropert, Martine, Lepage, Sylvie, Loréal, Olivier, Deniaud, David, Gaboriau, François

المساهمون: Foie, métabolismes et cancer, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Société d'Accélération du Transfert de Technologies (SATT OUEST VALORISATION), Chimie Et Interdisciplinarité : Synthèse, Analyse, Modélisation (CEISAM), Université de Nantes - UFR des Sciences et des Techniques (UN UFR ST), Université de Nantes (UN)-Université de Nantes (UN)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou, Laboratoire de Toxicologie Biologique et Médico-Légale, This work was supported by the development funds SATT Ouest-Valorisation and FEDER Europe (Brittany region). The authors are grateful to the Conseil Régional Pays de la Loire, to the French Ministry of Education, to the Ligue Nationale contre le Cancer (LNCC, Ille et Vilaine/Loire Atlantique), to the Association pour la Recherche sur le Cancer (ARC) and to the Centre National de la Recherche Scientifique (CNRS) for financial support.The authors thank P. Loyer (Inserm UMR991, Rennes, France) and I. Morel (CHU Pontchaillou, Rennes, France) for scientific assistance in the flow cytometry and LC/MSMS analyses, respectively.In vivo experiments were carried out in the animal handling facility of the university, the ARCHE platform of the Structure Fédérative de Recherche BIOSIT in Rennes (BiogenOuest and Cancéropôle Grand Ouest network).The histological analysis were carried out in the histopathological platform H2P2 of the Structure Fédérative de Recherche BIOSIT in Rennes (BiogenOuest and Cancéropôle Grand Ouest network).

المصدر: ISSN: 0006-2952.

مصطلحات موضوعية: Cancer, colon adenocarcinoma, Iron, Iron chelator, polyamine, polyamine transport system, tumor vectorization, MESH: Animals, MESH: Antineoplastic Agents/pharmacology, MESH: DNA, Neoplasm/biosynthesis, MESH: Eflornithine/pharmacology, MESH: Female, MESH: HCT116 Cells, MESH: Iron Chelating Agents/pharmacology, MESH: Mice, Nude, MESH: Molecular Targeted Therapy, MESH: Neoplasm Transplantation, MESH: Polyamines/antagonists & inhibitors, MESH: Biological Transport/drug effects, MESH: Cell Cycle/drug effects, MESH: Cell Survival/drug effects, MESH: Colonic Neoplasms/drug therapy, MESH: Colonic Neoplasms/metabolism, MESH: Colonic Neoplasms/pathology, Neoplasm/antagonists & inhibitors, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/26070250; hal-01163245; https://univ-rennes.hal.science/hal-01163245; https://univ-rennes.hal.science/hal-01163245/document; https://univ-rennes.hal.science/hal-01163245/file/Quilamine%20HQ1-44,%20an%20iron%20chelator.pdf; PUBMED: 26070250

الاتاحة: https://univ-rennes.hal.science/hal-01163245
https://univ-rennes.hal.science/hal-01163245/document
https://univ-rennes.hal.science/hal-01163245/file/Quilamine%20HQ1-44,%20an%20iron%20chelator.pdf
https://doi.org/10.1016/j.bcp.2015.06.001

المؤلفون: Ward, Carol, Meehan, James, Mullen, Peter, Supuran, Claudiu, Dixon, J. Michael, Thomas, Jeremy, Winum, Jean-Yves, Lambin, Philippe, Dubois, Ludwig, Pavathaneni, Nanda-Kumar, Jarman, Edward, Renshaw, Lorna, Um, In Hwa, Kay, Charlene, Harrison, David, Kunkler, Ian, Langdon, Simon

المساهمون: University of Edinburgh (Edin.), University of St Andrews Scotland, Università degli Studi di Firenze = University of Florence = Université de Florence (UniFI), Institut des Biomolécules Max Mousseron Pôle Chimie Balard (IBMM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), School for Oncology and Developmental Biology Maastricht (GROW), Maastricht University Maastricht -Maastricht University Medical Centre (MUMC), Maastricht University Maastricht, Cancer Research UK Edinburgh Centre Edinburgh, UK, University of Edinburgh (Edin.)-MRC Institute of Genetics and Molecular Medicine Edinburgh (IGMM), University of Edinburgh (Edin.)-Medical Research Council-Medical Research Council

المصدر: ISSN: 1949-2553 ; Oncotarget ; https://hal.umontpellier.fr/hal-03621514 ; Oncotarget, 2015, 6 (28), pp.24856-24870. ⟨10.18632/oncotarget.4498⟩.

مصطلحات موضوعية: breast cancer, carbonic anhydrase IX, hypoxia, invasion, tumour microenvironment, MESH: Animals, MESH: Antigens, Neoplasm, MESH: Cell Proliferation, MESH: Dose-Response Relationship, Drug, MESH: Drug Screening Assays, Antitumor, MESH: Female, MESH: Humans, MESH: Immunohistochemistry, MESH: Mice, Nude, MESH: Molecular Structure, MESH: Molecular Targeted Therapy, MESH: Spheroids, Cellular, MESH: Breast Neoplasms, MESH: Tissue Array Analysis, MESH: Xenograft Model Antitumor Assays, MESH: Carbonic Anhydrase IX, MESH: Carbonic Anhydrase Inhibitors, MESH: Carbonic Anhydrases, MESH: Cell Hypoxia, MESH: Cell Line

Relation: info:eu-repo/semantics/altIdentifier/pmid/26259239; PUBMED: 26259239; PUBMEDCENTRAL: PMC4694798

الاتاحة: https://hal.umontpellier.fr/hal-03621514
https://hal.umontpellier.fr/hal-03621514v1/document
https://hal.umontpellier.fr/hal-03621514v1/file/oncotarget-v6i28-4498.pdf
https://doi.org/10.18632/oncotarget.4498

المؤلفون: Leenhardt, Fanny, Alexandre, Marie, Guiu, Severine, Pouderoux, Stephane, Beaujouin, Melanie, Lossaint, Gerald, Philibert, Laurent, Evrard, Alexandre, Jacot, William

المساهمون: Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut régional de Cancérologie de Montpellier (ICM), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)

المصدر: ISSN: 0344-5704.

مصطلحات موضوعية: Clinical pharmacy, Clinical trial, Drug–drug interaction, Oncology breast cancer, MESH: Administration, Oral, MESH: Antineoplastic Agents, MESH: Piperazines, MESH: Professional Role, MESH: Prospective Studies, MESH: Pyridines, MESH: Breast Neoplasms, MESH: Drug Interactions, MESH: Drug Monitoring, MESH: Female, MESH: Humans, MESH: Molecular Targeted Therapy, MESH: Pharmacists, MESH: Pharmacy Service, Hospital, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

Relation: info:eu-repo/semantics/altIdentifier/pmid/34286354; hal-03631408; https://hal.science/hal-03631408; PUBMED: 34286354; WOS: 000675050200001

الاتاحة: https://hal.science/hal-03631408
https://doi.org/10.1007/s00280-021-04331-0

المؤلفون: Lo Sciuto, Alessandra, Fernández-Piñar, Regina, Bertuccini, Lucia, Iosi, Francesca, Superti, Fabiana, Imperi, Francesco

المساهمون: Department of Biology and Biotechnology "Charles Darwin", Institut Pasteur, Fondation Cenci Bolognetti - Istituto Pasteur Italia, Fondazione Cenci Bolognetti, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Università degli Studi di Roma "La Sapienza" = Sapienza University Rome (UNIROMA), Ultrastructural Infectious Pathology Section, Department of Technology and Health, Istituto Superiore di Sanità = National Institute of Health (ISS), Pasteur Network (Réseau International des Instituts Pasteur), Regina Fernández-Piñar is supported by a Post-doc fellowship from the Fundación Alfonso Martín Escudero (Spain). The work on essential periplasmic proteins in Francesco Imperi's laboratory is supported by a grant from the Pasteur Institute-Cenci Bolognetti Foundation.

المصدر: ISSN: 1932-6203.

مصطلحات موضوعية: MESH: Anti-Bacterial Agents, MESH: Drug Discovery, MESH: Pseudomonas aeruginosa, MESH: Drug Resistance, Bacterial, MESH: Humans, MESH: Microbial Sensitivity Tests, MESH: Molecular Targeted Therapy, MESH: Organisms, Genetically Modified, MESH: Periplasmic Proteins, MESH: Polymyxins, MESH: Pseudomonas Infections, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology

Relation: info:eu-repo/semantics/altIdentifier/pmid/25093328; PUBMED: 25093328; PUBMEDCENTRAL: PMC4122361

الاتاحة: https://riip.hal.science/pasteur-01181371
https://riip.hal.science/pasteur-01181371v1/document
https://riip.hal.science/pasteur-01181371v1/file/pone.0103784.pdf
https://doi.org/10.1371/journal.pone.0103784

المؤلفون: Chandini Bhaskar Naidu, Joanna Timmins, Fabienne Hans, Muge Senarisoy

المساهمون: Institut de biologie structurale (IBS - UMR 5075), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA)

المصدر: International Journal of Molecular Sciences, Vol 21, Iss 9226, p 9226 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, MDPI, 2020, 21 (23), pp.9226. ⟨10.3390/ijms21239226⟩
International Journal of Molecular Sciences, 2020, 21 (23), pp.9226. ⟨10.3390/ijms21239226⟩

مصطلحات موضوعية: DNA Repair, Review, lcsh:Chemistry, chemistry.chemical_compound, 0302 clinical medicine, MESH: Structure-Activity Relationship, Neoplasms, MESH: Molecular Targeted Therapy, inhibitors, MESH: Animals, MESH: Neoplasms, Molecular Targeted Therapy, MESH: DNA Glycosylases, lcsh:QH301-705.5, Spectroscopy, chemistry.chemical_classification, MESH: DNA Repair, 0303 health sciences, [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM], MESH: Gene Expression Regulation, Enzymologic, General Medicine, Base excision repair, 3. Good health, Computer Science Applications, DNA glycosylases, 030220 oncology & carcinogenesis, Disease Susceptibility, MESH: Enzyme Activation, DNA repair, MESH: Disease Susceptibility, Antineoplastic Agents, Biology, base excision repair, Catalysis, Gene Expression Regulation, Enzymologic, Inorganic Chemistry, 03 medical and health sciences, Structure-Activity Relationship, medicine, Animals, Humans, cancer, Physical and Theoretical Chemistry, Molecular Biology, 030304 developmental biology, MESH: DNA Damage, MESH: Humans, drug resistance, Mechanism (biology), Organic Chemistry, Cancer, medicine.disease, Enzyme Activation, Enzyme, chemistry, lcsh:Biology (General), lcsh:QD1-999, DNA glycosylase, Cancer cell, Cancer research, MESH: Antineoplastic Agents, DNA, DNA Damage

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6ab3aa7711b687ca486c60dd62a3c6
https://www.mdpi.com/1422-0067/21/23/9226

المؤلفون: Luis Enrique Cortés-Hernández, Zahra Eslami-S, Catherine Alix-Panabières

المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM)

المصدر: Cells
Cells, MDPI, 2020, 9 (8), pp.1836. ⟨10.3390/cells9081836⟩
Cells, Vol 9, Iss 1836, p 1836 (2020)

مصطلحات موضوعية: 0301 basic medicine, epithelial cancer, Epithelial-Mesenchymal Transition, Epithelial cancer, Review, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, circulating tumor cells, MESH: Neoplastic Cells, Circulating, MESH: Prognosis, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Circulating tumor cell, Neoplasms, MESH: Molecular Targeted Therapy, Biomarkers, Tumor, Humans, MESH: Neoplasms, Epithelial–mesenchymal transition, Molecular Targeted Therapy, Neoplasm Metastasis, lcsh:QH301-705.5, Metastatic cascade, MESH: Humans, Transition (genetics), Chemistry, Epithelial cell adhesion molecule, General Medicine, MESH: Gene Expression Regulation, Neoplastic, epithelial-tomesenchymal transition, Neoplastic Cells, Circulating, Prognosis, MESH: Neoplasm Metastasis, Gene Expression Regulation, Neoplastic, 030104 developmental biology, MESH: Epithelial-Mesenchymal Transition, lcsh:Biology (General), 030220 oncology & carcinogenesis, Cancer research, epithelial-to-mesenchymal transition, MESH: Biomarkers, Tumor, epithelial cell adhesion molecule, MESH: Epithelial Cell Adhesion Molecule

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36907ba8ed03087936667735777f1185
https://hal.umontpellier.fr/hal-03367929

المؤلفون: Fran Robson, Palma Rocchi, Sinem Demirbag, Thi Khanh Le, Khadija Shahed Khan, Clément Paris, Peter Barfuss, Wai-Lung Ng

المساهمون: University of Bristol [Bristol], The Chinese University of Hong Kong [Hong Kong], Centre de Recherche en Cancérologie de Marseille (CRCM), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Hanoi University of Science and Technology (HUST), Sabanci University, Nanotechnology Research and Application Center, Sabanci University [Istanbul], Université Paris-Est (UPE), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Rocchi, Palma

المصدر: Molecular Cell
Molecular Cell, Elsevier, 2020, 79 (5), pp.710-727. ⟨10.1016/j.molcel.2020.07.027⟩
Molecular Cell, 2020, 79 (5), pp.710-727. ⟨10.1016/j.molcel.2020.07.027⟩

مصطلحات موضوعية: antisense oligonucleotide, Transcription, Genetic, MESH: Coronavirus Infections, viruses, [SDV]Life Sciences [q-bio], Cell, coronavirus, Cytidine, Viral Nonstructural Proteins, medicine.disease_cause, Virus Replication, Genome, Severity of Illness Index, 0302 clinical medicine, Transcription (biology), MESH: Molecular Targeted Therapy, MESH: COVID-19, Nucleotide, MESH: Adenosine Monophosphate, Molecular Targeted Therapy, Coronavirus, chemistry.chemical_classification, 0303 health sciences, Alanine, non-structural protein 14, virus diseases, ExoN, MESH: Amides, 3. Good health, [SDV] Life Sciences [q-bio], medicine.anatomical_structure, 030220 oncology & carcinogenesis, MESH: Pyrazines, MESH: RNA, Viral, Pyrazines, Proofreading, MESH: Betacoronavirus, RNA, Viral, MESH: Genome, Viral, Coronavirus Infections, MESH: Cytidine, medicine.drug, MESH: Antiviral Agents, MESH: Pandemics, MESH: Mutation, exonuclease, MESH: Alanine, CoV, Pneumonia, Viral, antisense oligonucleotide (ASO), Computational biology, Genome, Viral, Biology, Therapeutic targeting, Hydroxylamines, Antiviral Agents, Article, ASO, 03 medical and health sciences, Betacoronavirus, MESH: Severity of Illness Index, Coronavirus (CoV), medicine, Humans, MESH: SARS-CoV-2, anti-coronavirus drugs, Molecular Biology, Pandemics, 030304 developmental biology, Exonuclease (ExoN), MESH: Ribonucleosides, MESH: Humans, Nucleoside analogue, SARS-CoV-2, MESH: Transcription, Genetic, MESH: Virus Replication, nucleoside analog, RNA, COVID-19, Correction, MESH: Hydroxylamines, Cell Biology, Amides, Adenosine Monophosphate, non-structural protein 14 (nsp14), respiratory tract diseases, nucleoside analogue (NA), Viral replication, chemistry, MESH: Pneumonia, Viral, Mutation, nsp14, MESH: Viral Nonstructural Proteins, NA, Ribonucleosides, 030217 neurology & neurosurgery

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e7c3d34b3a0e2ab6d0db7eece5c7f1
https://pubmed.ncbi.nlm.nih.gov/33338403

المؤلفون: Travert, Marion, Huang, Yenlin, de Leval, Laurence, Martin-Garcia, Nadine, Delfau-Larue, Marie-Helene, Berger, Françoise, Bosq, Jacques, Brière, Josette, Soulier, Jean, Macintyre, Elizabeth, Marafioti, Teresa, de Reyniès, Aurélien, Gaulard, Philippe

المساهمون: Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Département de pathologie Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Department of Anatomic Pathology, Chang Gung Memorial Hospital Taipei (CGMH), Service de Pathologie Clinique, Université de Lausanne = University of Lausanne (UNIL)-Centre Hospitalier Universitaire Vaudois = Lausanne University Hospital Lausanne (CHUV)-Institut Universitaire de Pathologie, Service d'immunologie biologique, Centre de Biologie et de Pathologie, Centre Hospitalier Lyon Sud CHU - HCL (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL)-Hôpital Renée Sabran CHU - HCL, Hospices Civils de Lyon (HCL), Département de biologie et pathologie médicales Gustave Roussy, Institut Gustave Roussy (IGR), Gvh et Gvl : Physiopathologie Chez l'Homme et Chez l'Animal, Incidence et Role Therapeutique, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'anatomo-pathologie Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunologie, dermatologie, oncologie, Oncodermatologie, immunologie et cellules souches cutanées (IDO (U976 / UMR_S 976)), Service hématologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Necker - Enfants Malades AP-HP, Department of histopathology, University College Hospital, (le programme) Cartes d'identité des tumeurs (CIT), Ligue Nationales Contre le Cancer (LNCC), This work is part of the Carte d'Identité des Tumeurs (CIT) program (http://cit.liguecancer.net/index.php/en) from the Ligue Nationale Contre le Cancer and of the Tenomic project inserm-00730464, version 1 - 10 Sep 2012 supported by a Programme Hospitalier de Recherche Clinique and the Institut National du Cancer (INCa). This work was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM), the Institut National du Cancer (INCa), the Plan cancer of the Belgian government, and the Association pour la Recherche Thérapeutique, Génétique et Immunologique dans les Lymphomes (ARTGIL). M.T. was supported by the Fondation pour la Recherche Médicale (DEQ 2010/0318253)

المصدر: ISSN: 0006-4971.

مصطلحات موضوعية: MESH: Aged, MESH: Gene Expression Regulation, Neoplastic, MESH: Genes, Neoplasm, MESH: Humans, MESH: Intracellular Signaling Peptides and Proteins, MESH: Isochromosomes, MESH: Liver Neoplasms, MESH: Lymphoma, T-Cell, MESH: Male, MESH: Membrane Proteins, MESH: Middle Aged, MESH: Base Sequence, MESH: Molecular Sequence Data, MESH: Molecular Targeted Therapy, MESH: Protein-Tyrosine Kinases, MESH: Receptors, Antigen, alpha-beta, gamma-delta, MESH: Splenic Neoplasms, MESH: Tumor Markers, Biological, MESH: Young Adult, MESH: Adult, MESH: Cell Lineage, MESH: Chromosome Aberrations, MESH: Cluster Analysis

Relation: info:eu-repo/semantics/altIdentifier/pmid/22510872; PUBMED: 22510872

الاتاحة: https://inserm.hal.science/inserm-00730464
https://inserm.hal.science/inserm-00730464v1/document
https://inserm.hal.science/inserm-00730464v1/file/HSTLsubmit.bloodjournalRevision.pdf
https://inserm.hal.science/inserm-00730464v1/file/inserm-00730464_edited.pdf
https://doi.org/10.1182/blood-2011-12-396150

المؤلفون: Hirsch, Etienne, C.

المساهمون: Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (CRICM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: ISSN: 0001-4079.

مصطلحات موضوعية: Parkinson disease, Dopamine, Inflammation, Accidental falls, MESH: Adaptive Immunity, MESH: Animals, MESH: Forecasting, MESH: Haplorhini, MESH: Humans, MESH: Magnetic Resonance Imaging, MESH: Mice, MESH: Molecular Targeted Therapy, MESH: Nerve Degeneration, MESH: Neuroprotective Agents, MESH: Oxidative Stress, MESH: Parkinson Disease, MESH: Antiparkinson Agents, MESH: Parkinsonian Disorders, MESH: Brain, MESH: Cation Transport Proteins, MESH: Cell Death, MESH: Cholinergic Neurons, MESH: Deep Brain Stimulation, MESH: Dopamine Agonists, MESH: Dopaminergic Neurons, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]

Relation: info:eu-repo/semantics/altIdentifier/pmid/23815021; inserm-00850568; https://inserm.hal.science/inserm-00850568; https://inserm.hal.science/inserm-00850568/document; https://inserm.hal.science/inserm-00850568/file/HIRSCH_Version_16_1_12_2_RevueBullAcadMed.pdf; PUBMED: 23815021

الاتاحة: https://inserm.hal.science/inserm-00850568
https://inserm.hal.science/inserm-00850568/document
https://inserm.hal.science/inserm-00850568/file/HIRSCH_Version_16_1_12_2_RevueBullAcadMed.pdf

المؤلفون: Jebali, Jed J., Jeanneau, Charlotte, Ch, Bazaa, Amine, A., Mathieu, Sylvie, S., El Ayeb, Mohamed, M., Luis, José, J., El Battari, Assou, A., Marrakchi, Naziha, N.

المساهمون: Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Laboratoire de Valorisation de la Biomasse et Production de Protéines chez les Eucaryotes (CBS), Centre de Biotechnologie de Sfax (CBS), Centre de Recherches en Oncologie biologique et Oncopharmacologie (CRO2), Aix Marseille Université (AMU)-Hôpital de la Timone CHU - APHM (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté de Médecine, Faculte de Medecine de Tunis

المصدر: ISSN: 0020-2509 ; Archives de l'Institut Pasteur de Tunis ; https://riip.hal.science/pasteur-00755430 ; Archives de l'Institut Pasteur de Tunis, 2011, 88 (1-4), pp.3-18.

مصطلحات موضوعية: Selectins, sialyl-Lewis, adhesion, inflammation, tumor progression, sélectines, adhérence, progression tumorales, MESH: Cell Adhesion Molecules, MESH: Humans, MESH: Molecular Targeted Therapy, MESH: Selectins, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM]

Relation: info:eu-repo/semantics/altIdentifier/pmid/23461138; pasteur-00755430; https://riip.hal.science/pasteur-00755430; https://riip.hal.science/pasteur-00755430/document; https://riip.hal.science/pasteur-00755430/file/J.Jebali_et_Coll.pdf; PUBMED: 23461138

الاتاحة: https://riip.hal.science/pasteur-00755430
https://riip.hal.science/pasteur-00755430/document
https://riip.hal.science/pasteur-00755430/file/J.Jebali_et_Coll.pdf

المؤلفون: Facchinetti, Francesco, Hollebecque, Antoine, Bahleda, Rastislav, Loriot, Yohann, Olaussen, Ken, Massard, Christophe, Friboulet, Luc

المساهمون: Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay

المصدر: ISSN: 1078-0432.

مصطلحات موضوعية: MESH: Clinical Trials as Topic, MESH: Clinical Trials, Phase III as Topic, MESH: Humans, MESH: Molecular Targeted Therapy, MESH: Neoplasms, MESH: Protein Kinase Inhibitors, MESH: Randomized Controlled Trials as Topic, MESH: Receptors, Fibroblast Growth Factor, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/31585937; hal-04500212; https://hal.science/hal-04500212; PUBMED: 31585937; PUBMEDCENTRAL: PMC7024606

الاتاحة: https://hal.science/hal-04500212
https://doi.org/10.1158/1078-0432.CCR-19-2035

المؤلفون: Hans, Fabienne, Senarisoy, Muge, Naidu, Chandini Bhaskar, Timmins, Joanna

المساهمون: Institut de biologie structurale (IBS - UMR 5075), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA)

المصدر: ISSN: 1661-6596.

مصطلحات موضوعية: DNA glycosylases, base excision repair, cancer, drug resistance, inhibitors, MESH: Animals, MESH: Antineoplastic Agents, MESH: Neoplasms, MESH: Structure-Activity Relationship, MESH: DNA Damage, MESH: DNA Glycosylases, MESH: DNA Repair, MESH: Disease Susceptibility, MESH: Enzyme Activation, MESH: Gene Expression Regulation, Enzymologic, MESH: Humans, MESH: Molecular Targeted Therapy, [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM]

Relation: info:eu-repo/semantics/altIdentifier/pmid/33287345; PUBMED: 33287345; PUBMEDCENTRAL: PMC7730500

الاتاحة: https://hal.univ-grenoble-alpes.fr/hal-03184050
https://doi.org/10.3390/ijms21239226